Literature DB >> 3001153

Observer variability in reporting of breast lesions.

J S Beck.   

Abstract

The consistency of histological diagnosis of breast lesions by members of the panel was studied using a simplified six point classification system that covered the range from normal tissue to invasive carcinoma. In a representative set of 40 sections of the range of breast disease included in the Trial for Early Detection of Breast Carcinoma (the consecutive series), there was, overall, 82% agreement between the diagnoses submitted by members of the panel: diagnosis was virtually consistent (99% agreement) for frankly invasive carcinoma, but there was much greater variability in the diagnosis of borderline lesions. Diagnostic consistency was greatly improved when two categories only (benign and malignant) were considered (94% agreement). The diagnostic consistency of individual pathologists was studied by recirculating the sections: the overall agreement was 78% and, again, most of the inconsistencies occurred when borderline lesions were diagnosed. Additional studies were undertaken on borderline lesions that had been flagged during the first two years of the trial (the borderline series). Unsurprisingly, there was less agreement among the pathologists when all six diagnostic categories were used (70% and 77% for the specimens from the first and second years, respectively), but consistency was greatly improved when classification was simplified to either benign or malignant (86% and 91%, respectively). The diagnoses submitted by individual pathologists were found to deviate from the "majority" diagnosis to a relatively minor extent: each pathologist was generally consistent in either under-diagnosing or overdiagnosing in both the consecutive and borderline series.

Entities:  

Mesh:

Year:  1985        PMID: 3001153      PMCID: PMC499493          DOI: 10.1136/jcp.38.12.1358

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies.

Authors:  A S Patchefsky; J Potok; W S Hoch; H I Libshitz
Journal:  Am J Clin Pathol       Date:  1973-12       Impact factor: 2.493

2.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Ten- to fourteen-year effect of screening on breast cancer mortality.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

5.  Combined external quality assessment of cytology and histology opinions: a pilot scheme for a cluster of five laboratories.

Authors:  O Husain; E B Butler; F P Woodford
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Lobular carcinoma in situ: (lobular neoplasia) of the breast (a symposium).

Authors:  J A Andersen; R E Fechner; R Lattes; P P Rosen; C Toker
Journal:  Pathol Annu       Date:  1980

7.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

8.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

9.  Histopathological systems of breast cancer classification: reproducibility and clinical significance.

Authors:  B Stenkvist; E Bengtsson; O Eriksson; T Jarkrans; B Nordin; S Westman-Naeser
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  Observer variation in the histological grading of rectal carcinoma.

Authors:  G D Thomas; M F Dixon; N C Smeeton; N S Williams
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

  10 in total
  9 in total

1.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

2.  Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.

Authors:  Kimberly H Allison; Mara H Rendi; Sue Peacock; Tom Morgan; Joann G Elmore; Donald L Weaver
Journal:  Histopathology       Date:  2016-09-23       Impact factor: 5.087

3.  Observer variability in histopathological reporting of cervical biopsy specimens.

Authors:  A J Robertson; J M Anderson; J S Beck; R A Burnett; S R Howatson; F D Lee; A M Lessells; K M McLaren; S M Moss; J G Simpson
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

4.  Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders.

Authors:  A J Robertson; J S Beck; R A Burnett; S R Howatson; F D Lee; A M Lessells; K M McLaren; S M Moss; J G Simpson; G D Smith
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

5.  Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia.

Authors:  S M Ismail; A B Colclough; J S Dinnen; D Eakins; D M Evans; E Gradwell; J P O'Sullivan; J M Summerell; R G Newcombe
Journal:  BMJ       Date:  1989-03-18

6.  Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.

Authors:  L Pedersen; S Holck; T Schiødt; K Zedeler; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

7.  Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel.

Authors:  Kimberly H Allison; Lisa M Reisch; Patricia A Carney; Donald L Weaver; Stuart J Schnitt; Frances P O'Malley; Berta M Geller; Joann G Elmore
Journal:  Histopathology       Date:  2014-04-02       Impact factor: 5.087

8.  Intraobserver reproducibility in assigning brain tumors to classes in the World Health Organization diagnostic scheme. The Childhood Brain Tumor Consortium.

Authors: 
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

9.  Evaluation of mitotic activity index in breast cancer using whole slide digital images.

Authors:  Shaimaa Al-Janabi; Henk-Jan van Slooten; Mike Visser; Tjeerd van der Ploeg; Paul J van Diest; Mehdi Jiwa
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.